Market Scenario:
The Diabetes Market in India is well-established & growing pervasively with the rapid pace. Growing prevalence of diabetes fuelled by the changing lifestyle, inclination towards the sedentary lifestyle & growing obesity disorder among people, are some of the predominant driving force contributing to the market growth. Introduction of the novel medicines & therapies, giving the best outcomes is providing impetus to the market growth. This, in turn, is supporting the market growth of Diabetes in India.
The Diabetes market in India will reach to USD 7441.6 million by 2023, posting a striking CAGR during 2017 – 2023. The market had valued USD 4778.7 million in 2016.
Evidently, technological advancements transpired into the field of medical science is also predominant factor propelling the market growth, escalating it pervasively. Seminal efforts & investments put in the development of innovative drugs & therapies, by the key market players to control diabetes are paying off well driving the market growth. Initiatives taken by the Government are playing a major role in fostering the market growth.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2966
On the other hand, factors such as low awareness among people about diabetes treatment, the high manufacturing cost of diabetes management devices along with the skepticism of physicians towards the advancement & efficacies of these devices are likely to impede the growth of India Diabetes market. However, the demand for sophisticated devices by the physicians and patients, in turn, is contributing to the market growth to a great extent.
Segments:
India Diabetes Market has been segmented on the basis of type which comprise Type 1, Type 2, and Gestational diabetes. On the basis of test market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment, market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.
Regional Analysis of India Diabetes Market:
Considering the scenario of the Indian diabetes market, western region is believed to be the largest market for diabetes. Moreover the Eastern and Northern regions are also growing and second largest market for India Diabetes. On the other hand, Southern Indian market is expected to grow at significant rate in the India diabetes during the forecasted period. Central region is likely to have a limited but moderate growth in the market.
Key Players for India Diabetes Market:
Some of the key players in this market are: Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland)
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2966
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
…Continued
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/2966
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/diabetes-market-2966